Trial intelligence / Profile preview

Intravenous Ferritin for Postoperative Recovery in Pancreaticoduodenectomy

NCT06442111Not yet recruiting

Sponsor
Seoul St. Mary's Hospital
Start
Jul 2024
Primary completion
Jun 2025
Modality
Small Molecules
01

Overview

Randomised trial in iron deficiency anemia (IDA) comparing Intravenous Ferritin Group with Placebo Group (2 arms). Primary endpoint: Number of hemoglobin responders at 12 weeks. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT06442111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06442111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call